POSA168 Meta-Analysis and Cost-Effectiveness Analysis of Oxaliplatin-Based Chemotherapy Versus Irinotecan-Based Chemotherapy for the First-Line Treatment of Metastatic Advanced Colorectal Cancer in China
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.309
https://www.valueinhealthjournal.com/article/S1098-3015(21)02104-5/fulltext
Title :
POSA168 Meta-Analysis and Cost-Effectiveness Analysis of Oxaliplatin-Based Chemotherapy Versus Irinotecan-Based Chemotherapy for the First-Line Treatment of Metastatic Advanced Colorectal Cancer in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02104-5&doi=10.1016/j.jval.2021.11.309
First page :
Section Title :
Open access? :
No
Section Order :
11083